Global Urodynamic Devices Market Overview:
The global urodynamic devices market is expected to witness marginal growth due to the rising incidence of kidney and urinary tract diseases across the globe. An increase in healthcare initiatives being undertaken to create awareness about urological problems and available diagnostics & treatment is anticipated to the global urodynamic devices market in the forecast period. According to AMA, the Global Urodynamic Devices market is expected to see growth rate of 6.93%
Growth Drivers
- Increasing Geriatric Population and Increasing High Incidence of Urologic Conditions
- Rise in Healthcare Initiatives being Undertaken to create Awareness about Urological Problems and Available Diagnostics &Treatment
Market Trends
- Technological Advancements in Urodynamic Equipment
Roadblocks
- Strict Rules and Regulation Regarding Urodynamic Devices
Opportunities
- Technological Advancements, such as Doppler Ultrasound Video Urodynamic, Condom Catheter, Intravesical Prostatic Protrusion, and Penile Cuff, are also amongst major Growth Contributors
Challenges
- High Cost Associated With Urodynamic Devices
Competitive Landscape:
Some of the key players profiled in the report are Laborie, Inc. (United States), CooperSurgical Inc. (United States), Medtronic Plc (United States), Coloplast (Denmark), Albyn Medical S.L. (Spain), Boston Scientific Corporation (United States), Spain Medical Measurement Systems B.V. (Netherlands), Roper Technologies, Inc. (United States), Karl Storz SE & Co. KG (Germany), Olympus Corporation (Japan) and Palex Medical SA (Spain). Additionally, following companies can also be profiled that are part of our coverage like Aymed Medical Technology (Turkey), HC ITALIA srl (Italy), SRS Medical Systems, Inc. (United States), The Prometheus Group (United States), Tic Medizintechnik (Germany) and Wallach Surgical Devices (United States). Analyst at AMA Research see European and United States Players to retain maximum share of Global Urodynamic Devices market by 2026. Considering Market by End User, the sub-segment i.e. Hospitals and Urology Clinics will boost the Urodynamic Devices market.
Latest Market Insights:
In April 2019, Boston Scientific Corporation has announced that it has entered into a four-year exclusive marketing agreement with Bladder Health Network (BHN), a privately held company offering advanced testing solutions for urinary incontinence. BHN offers an integrated diagnostic solutions platform that combines software, staffing, equipment, supplies and results analysis, providing physicians and their patients with greater access to testing, interpretation and treatment options for urinary incontinence and other problems related to the urinary system.
Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase
Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Urodynamic Devices market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Urodynamic Devices market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Urodynamic Devices Manufacturers, Research Organizations and Consulting Companies, Potential Technology Investors, Regulatory & Government Bodies, Downstream Vendors, End Users and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.